IMMP · Immutep Limited ADR
United States · RS rating 82 · As of 2026-11-03
| Price | 3.00 USD |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 12 / 98 / 87 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 32 / 56 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +38.1% |
| Market cap (USD) | $84.1M |